The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA212314
Max Phase: Preclinical
Molecular Formula: C14H10BrClN2O2S3
Molecular Weight: 449.80
Molecule Type: Small molecule
Associated Items:
Representations Synonyms (1): AW-00430 Synonyms from Alternative Forms(1):
Canonical SMILES: Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(Br)cc3Cl)s2)cs1
Standard InChI: InChI=1S/C14H10BrClN2O2S3/c1-8-17-12(7-21-8)13-4-5-14(22-13)23(19,20)18-11-3-2-9(15)6-10(11)16/h2-7,18H,1H3
Standard InChI Key: AMNKYHFERGWVCB-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 449.80Molecular Weight (Monoisotopic): 447.8776AlogP: 5.40#Rotatable Bonds: 4Polar Surface Area: 59.06Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.55CX Basic pKa: 2.25CX LogP: 4.59CX LogD: 4.39Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.58Np Likeness Score: -2.46
References 1. Delfín DA, Bhattacharjee AK, Yakovich AJ, Werbovetz KA.. (2006) Activity of and initial mechanistic studies on a novel antileishmanial agent identified through in silico pharmacophore development and database searching., 49 (14): [PMID:16821779 ] [10.1021/jm060156v ] 2. PubChem BioAssay data set,